BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang W, Lei W, Jiang L, Gao S, Hu S, Zhao ZG, Niu CY, Zhao ZA. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment. J Transl Med 2021;19:198. [PMID: 33971907 DOI: 10.1186/s12967-021-02862-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Muñoz MF, Marotta F, Ahmadi AM, Yazdani A, He F, Catanzaro R, Garzón-rodriguez C, Ayala A. Anti-aging and Rejuvenation Based on Stem Cell Therapy. Emerging Anti-Aging Strategies 2023. [DOI: 10.1007/978-981-19-7443-4_5] [Reference Citation Analysis]
2 Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022;7:272. [PMID: 35933430 DOI: 10.1038/s41392-022-01134-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wiercinska E, Bönig H. Zelltherapie in den Zeiten von SARS-CoV-2. Transfusionsmedizin 2022;12:148-155. [DOI: 10.1055/a-1720-7975] [Reference Citation Analysis]
4 Kirkham AM, Bailey AJM, Monaghan M, Shorr R, Lalu MM, Fergusson DA, Allan DS. Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval-FASTER Approval. Stem Cells Transl Med 2022:szac038. [PMID: 35758400 DOI: 10.1093/stcltm/szac038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan) 2021;13:14. [PMID: 34872623 DOI: 10.1186/s41479-021-00092-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
6 Li X, Yan M, Chen J, Luo Y. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19. Biomed Res Int 2021;2021:3178796. [PMID: 34840969 DOI: 10.1155/2021/3178796] [Reference Citation Analysis]
7 Li C, Zhao H, Cheng L, Wang B. Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice. Cell Biosci 2021;11:187. [PMID: 34727974 DOI: 10.1186/s13578-021-00698-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
8 Infante A, Rodríguez CI. Cell and Cell-Free Therapies to Counteract Human Premature and Physiological Aging: MSCs Come to Light. J Pers Med 2021;11:1043. [PMID: 34683184 DOI: 10.3390/jpm11101043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wong SW, Lenzini S, Giovanni R, Knowles K, Shin JW. Matrix biophysical cues direct mesenchymal stromal cell functions in immunity. Acta Biomater 2021;133:126-38. [PMID: 34365041 DOI: 10.1016/j.actbio.2021.07.075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Dunlap NE, van Berkel V, Cai L. COVID-19 and low-dose radiation therapy. Radiat Med Prot 2021. [PMID: 34522905 DOI: 10.1016/j.radmp.2021.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]